FST and rheumatoid arthritis: However, follistatin levels were not associated with the type of treatment; therefore, follistatin concentration cannot be taken as a guidance to select the Disease-Modifying Anti-Rheumatic Drugs (DMARDs) or anti-TNF agents in RA.